Viewing Study NCT05338502


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-06-19 @ 4:19 PM
Study NCT ID: NCT05338502
Status: COMPLETED
Last Update Posted: 2024-10-30
First Post: 2022-04-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants
Sponsor: Eli Lilly and Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 17574
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View